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NF-Y binds a CCAAT motif found in many eukaryotic
polymerase II-dependent promoters. In the HLA-DRA
promoter it has been demonstrated that stereo-specific
alignment between this motif and the upstream
elements Xl and X2 is required for activation. To
study the underlying mechanism for this requirement,
a panel of transfected cell lines that maintained
integrated, wild-type and mutant promoters were
analyzed by in vivo genomic footprinting. Cell lines
harboring a mutated CCAAT element exhibited a loss
of interactions at the CCAAT site, as expected, and no
transcriptional activity. Most importantly, mutation of
the CCAAT sequence nearly abolished in vivo binding
at the Xl and X2 sites, while mutations of Xl and X2
had little effect on CCAAT box binding. However,
Xl and X2 binding was interdependent. In vitro, Xl
binding activities are known to be stabilized by NF-Y
binding. Interaction between NF-Y and X box binding
proteins was demonstrated by reciprocal co-immuno-
precipitation in the absence of DNA and co-affinity
purification in the presence of DNA. Collectively, these
studies indicate that occupancy of the CCAAT element
represents an early event affecting other protein-DNA
interactions and suggest that NF-Y stabilizes and inter-
acts with X box factors to mediate this function.
These findings may represent a common theme among
promoters containing a CCAAT element.
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Introduction
Extensive studies of eukaryotic promoters have revealed
complex arrangements of multiple proximal elements,
often combined with distal enhancers and silencers. Many
of the individual trans-acting factors have now been
isolated and cloned, facilitating the determination of their
potential function. However, there is only limited under-
standing of the mechanisms by which multiple factors
work together to produce regulated expression. Some of
the clearest demonstrations of factor interaction come
from studies of upstream factors contacting the basal
transcription machinery. For example, the transcription
factor SpI appears to bind directly to the TATA-associated
factor TAF110 (Hoey et al., 1993), while other acidic
activators can recruit TFIIB and TBP (Stringer et al.,
1990; Lin and Green, 1991; Choy and Green, 1993).
Another of the better understood mechanisms involves the
modulation of local chromatin structure to allow access
by additional factors. In the mouse mammary tumor virus
promoter, chromatin structure prevents NFI binding to
the promoter (Pina et al., 1990; Archer et al., 1991).
Induction of glucocorticoid receptor binding to DNA
disrupts the nucleosomes over the NFl site and allows
binding and activation of transcription. Similar roles in
nucleosomal disruption or positioning have been demon-
strated for HNF-3-like factors on the albumin promoter
in vivo (McPherson et al., 1993) and for the GAGA factor
on the hsp7O promoter in vitro (Tsukiyama et al., 1994).
Alone, these two mechanisms are insufficient to account
for the diverse levels of synergy and repression seen
on natural promoters. Additional interactions between
neighboring DNA binding regulatory factors could play a
significant role. These types of interactions could modulate
not only the activating potential of a factor, but also its
DNA binding affinity and its interactions with non-DNA
binding proteins. While many cases of functional synergy
between DNA binding factors have been described (e.g.
Fromental et al., 1988; Atchison et al., 1990; Bruggemeier
et al., 1991; Li et al., 1991; Milos and Zaret, 1992; Du
et al., 1993; Gegonne et al., 1993), the mechanisms are
less well defined. Thus, determining which factors are
able to interact functionally and physically will be an
important key to understanding multi-component promoter
regulation.
Several approaches have been utilized to directly
examine protein-protein interaction. Co-immunoprecipi-
tation of endogenous factors directly from cell lysates has
been essential in determining the components of obligatory
dimeric DNA binding factors such as myc/max and NF-
icB (Blackwood et al., 1992; Ruben et al., 1992). However,
this approach has had only limited success in detecting
the weaker interactions between non-dimeric neighboring
factors and usually has required the addition of recom-
binant protein. In addition, co-immunoprecipitation in the
presence of DNA containing one of the factor binding
sites has been successful when direct precipitation was
not (Li et al., 1991). This may indicate that the DNA
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plays an active role in these types of interactions. Further-
more, many examples exist of an increase in the in vitro
DNA binding affinity or half-life of protein-DNA inter-
actions upon the binding of a neighboring factor, although
the mechanisms are unknown (Giniger and Ptashne, 1988;
Janson and Pettersson, 1990; Xiao et al., 1991). Functional
methods have also been developed to detect these inter-
actions, such as the reconstitution of chimeric GAL4 or
LexA transactivators through the interaction of the proteins
being tested (Blackwood and Eisenman, 1991; Chien et al.,
1991; Dang et al., 1991; Fearon et al., 1992; Fujii et al.,
1992). Although informative, the procedure is limited by
the complete dependence on recombinant proteins and
faithful reproduction of the native protein structure in the
chimeric molecules. A caveat of all these approaches is
that they are done in the absence of the natural context
of the promoter, where neighboring proteins and the
chromatin environment may play significant roles. To
address these issues using a physiological promoter in
an intact chromatin environment, we have adapted the
procedure of in vivo genomic footprinting to detect the
hierarchy and interdependence of transcription factors
bound to functional class II major histocompatibility
promoter sequences in intact cells (Mueller and Wold,
1989). These studies are then complemented by biochem-
ical evidence showing protein interactions among tran-
scription factors specific for this promoter.
The major histocompatibility complex (MHC) class II
genes provide an appropriate and physiologically import-
ant context in which to study upstream promoter assembly
(reviewed in Benoist and Mathis, 1990; Peterlin et al.,
1990; Glimcher and Kara, 1991; Ting and Baldwin, 1993).
The MHC class II molecules have a central role in the
immune response by presenting antigen on the surface of
cells which is then recognized by the T cell receptor of
class 1I-restricted T cells. This recognition is important
in the selection of an appropriate T cell repertoire in the
thymus, as well as the elicitation of an immune response
in the peripheral lymphoid organs. Control of class II
MHC gene expression is physiologically critical, as
demonstrated by disease states characterized by either
a lack of expression (bare lymphocyte syndrome) or
hyperexpression (diabetes mellitus, multiple sclerosis,
rheumatoid arthritis) of these molecules.
Previous studies have shown that the promoter of
class II genes contains a number of functional upstream
elements. Of importance in this study are the trimeric S,
X box (XI and X2) and Y/CCAAT elements. These ele-
ments are highly conserved in all murine and human class
II genes and are separated from one another by a conserved
distance. Analysis of constitutive and y-IFN-induced MHC
class II DRA expression has identified the stereo-specific
alignment between the X box and Y/CCAAT elements as
critical in promoter function (Vilen et al., 1990). Analysis
of the conserved distance separating the S and X elements
revealed that any change in the distance, regardless of
helical orientation, dramatically reduced the positive
regulatory effects of these elements (Vilen et al., 1992).
Collectively, these findings are consistent with a model
where protein-protein interactions are required between
factors specific for the XI/X2 and Y/CCAAT elements
and possibly with the S element.
A number of recombinant proteins can bind to the XI,
X2 and Y/CCAAT elements. The heterodimeric NF-Y
(also referred to as CBF, CP1 and YEBP) binds the
Y/CCAAT element (Dom etal., 1987; Chodosh et al.,
1988b; Maity et al., 1988; Zeleznik-Le et al., 1991). rRF-
X has been shown to bind the XI site, although it is less
clear that this recombinant protein functions in MHC class
II transcription (Reith et al., 1990). The X2 site is similar
in sequence to known AP-1 sites and has been shown to
bind Jun/Fos as well as hXBP and mXBP (Liou,H.-L.
et al., 1988; Liou,H.-C. et al., 1990; Andersson and
Peterlin, 1990). Functional analysis by reconstitution of
in vitro transcription or blocking by NF-Y antibodies has
directly demonstrated that class II MHC promoters are
regulated by NF-Y (Zeleznik-Le et al., 1991; Mantovani
et al., 1992). Indirect evidence using anti-sense oligo-
nucleotides targeted to rRF-X and hXBP also shows
possible involvement of these two factors in the control
of class II MHC transcription (Ono et al., 1991; Reith
et al., 1990).
NF-Y is a member of the CCAAT box binding family
of proteins which is distinct in structure as well as binding
specificity from the other known CCAAT box binding
proteins, CTF/NF-1 and C/EBP (Dorn et al., 1987). In
addition to the class II MHC promoters, NF-Y can bind
and functionally regulate through the CCAAT elements
of a number of other promoters (Maity et al., 1988;
Wuarin et al., 1990; Zeleznik-Le et al., 1991; Milos and
Zaret, 1992). The A and B subunits of NF-Y bear striking
homology to the yeast transcription factors HAP3 and
HAP2 respectively and are functionally interchangeable
in a DNA binding assay (Chodosh et al., 1988b). This
evolutionary conservation from yeast to humans is reminis-
cent of the TATA binding protein (TBP) conservation
(Hooft van Huijsduijnen et al., 1990; Hemandez, 1993).
Another parallel between TATA and CCAAT elements is
that they occupy fixed locations in the promoter, the
former at -25 to -30 bp and the latter at -60 to -80 bp
(Bucher, 1990). A survey of 502 unrelated promoter
sequences shows that most CCAAT boxes located at this
position are NF-Y, but not C/EBP or NF-1, binding sites
(Bucher, 1990). Finally, in vitro transcription analyses
show that NF-Y and its target CCAAT element are
important for transcription re-initiation, suggesting a role
in basal transcription (Mantovani et al., 1992; Milos and
Zaret, 1992).
To explore the role of NF-Y in class II MHC transcrip-
tion, its interaction with X box binding proteins and
its general role in the assembly of proximal promoter
complexes, we have taken two complementary approaches.
First, cell lines which maintain stable, integrated DRA
promoter-reporter constructs with specific mutations in
the known cis-acting elements were produced. These
integrated promoters were analyzed by genomic foot-
printing and revealed a hierarchy of protein-DNA inter-
actions leading to a stable upstream promoter complex.
Importantly, binding to Y/CCAAT is an early and crucial
event required for binding at the Xl and X2 elements.
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Second, several lines of biochemical experimentation show
that recombinant and endogenous NF-Y proteins can
stabilize and interact with endogenous X box binding
proteins, thus providing a molecular basis for the potential
recruitment of X factors by NF-Y
Results
Stereo-specific alignment and distance constraints
among three promoter elements suggest a multi-
protein-DNA complex
The S, X and Y/CCAAT elements function in both
constitutive and y-IFN-induced expression of the DRA
promoter. Previously we have shown that the helical
alignment between X and Y/CCAAT, in addition to the
absolute spacing between S and X, are important for
constitutive expression and y-IFN induction (Figure lA
and B; Vilen et al., 1990). Addition of 0.5, 1.5, 3.5 or 5.5
helical turns between X and Y destroyed promoter func-
tion, while an additional one to six helical turns maintained
promoter function. Addition of either a half (S+5XY) or
one (S+ lOXY) helical turn between S and X abrogated the
y-IFN response. These results reveal that strict structural
constraints between three conserved upstream promoter
elements are required for promoter function, suggesting
that multi-protein complexes may be formed by the
proteins which bind these elements.
Production of stable transfectants for in vivo
genomic footprint analysis
To assess interactions among proteins specific for the S,
Xl, X2 and Y/CCAAT elements, both in vivo and in vitro
strategies were used. For the in vivo strategy, a panel of
stably transfected cells lines harboring wild-type or mutant
promoter constructs were produced and analyzed by
genomic footprinting to decipher the influence of indi-
vidual protein-DNA interactions on protein binding to
adjacent DNA elements. Stable transfectants were estab-
lished in the glioblastoma cell line U373-MG, in which
we have previously defined the endogenous DRA in vivo
footprint and y-IFN induction of class II expression (Moses
et al., 1992; Wright and Ting, 1992). A wild-type DRA
promoter-CAT fusion construct or one of four specific
promoter mutants (Figure IC) were stably integrated into
the genome of the glioblastoma cell line. Analysis of the
transcriptional activity of multiple monoclonal cell lines
revealed that the wild-type DRA promoter was expressed
at a low basal level, but could be induced -3-fold upon
y-IFN stimulation (Figure IC, WT). This result parallels
the endogenous DRA transcription previously reported.
Mutations in the Y/CCAAT box (mutY) or Xl box
(mutXl) diminished basal and y-IFN-induced expression
to nearly undetectable levels. The X2 box mutation
(mutX2) had no significant effect on transcription and did
not diminish the level of y-IFN induction. The S element
was also required for y-IFN induction of transcription.
Together these data indicate that the S, Xl and Y/CCAAT
elements are required for promoter function in stably
transfected cells.
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Fig. 1. Transient transfection and stable cell line analysis of the S,
X1/X2 and Y/CCAAT promoter elements reveals that their integrity
and stereo-specific alignment are required for DRA promoter function.
(A) Schematic of HLA-DRA upstream promoter elements with
changes in the relative spacing between S, X1/X2 and Y/CCAAT.
Promoter activity of the various spacing mutants following y-IFN
induction in transiently transfected U373-MG cells is shown in a
representative CAT assay. The small triangles represent 5 bp
insertions, while larger triangles represent 10 bp insertions. Shaded
elements are functionally important in the U373-MG glioblastoma cell
line, while the non-shaded octamer site is not utilized (Wright and
Ting, 1992). T, TATA; 0, octamer; Y, CCAAT. (B) Insertion of as
many as six additional helical turns maintains DRA promoter function.
The number of inserted helical turns between XI/X2 and Y/CCAAT is
depicted in the name of the construct. The results are presented as
normalized means and standard errors of the mean (SEM) of three
independent transient transfections. The octamer site (0) is shaded in
the schematic of the constructs as this site is functional in Raji B cells.
(C) The promoter elements S, XI and Y/CCAAT sites are required for
y-IFN inducibility in stably transfected cell lines. Schematic of mutant
promoter constructs and promoter activity in stable cell lines of
U373-MG. The normalized CAT data with SEM is an average from
four to eight independent monoclonal cell lines. A second distinct
vector, 5'A-56SXY was also utilized to carry the wild-type promoter
(Vilen et al, 1992) and no significant differences were detected,
indicating an independence from vector influences.
In vivo footprint analysis of the endogenous and
integrated DRA promoter shows indistinguishable
patterns
The importance of the S, X1, X2 and Y/CCAAT elements
in y-IFN induced DRA promoter assembly was addressed
by ligation-mediated PCR in vivo genomic footprinting
(Mueller and Wold, 1989). We have focused on y-IFN
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Fig. 2. In vivo genomic footprints of stably transfected cell lines reveals an indistinguishable binding pattern on the endogenous DRA promoter and
the introduced wild-type DRA promoter. This pattern was identical to the DRA footprint seen in untransfected cells (Wright and Ting, 1992). Only
the upper strand sequence is shown and a summary of all of the contact points are shown in (B). (A) Gene-specific primers selectively reveal only
the endogenous (lanes 1-4) or introduced DRA promoter (lanes 5 and 6) in the same cells. Lanes 1-2, wild-type stable cell line, endogenous DRA
footprint; lanes 3-4, mutY DRA stable cell line, endogenous DRA footprint; lanes 5-6, wild-type stable cell line, introduced DRA footprint.
Functional elements are indicated on the left side of each footprint and the contact points are marked on the right side. Strong and weak protections
are both indicated by an open circle, but are delineated in the text. Closed circles represent enhancements. Cont., in vitro methylated, deproteinized
DNA; DMS, in vivo methylated DNA 48 h after y-IFN induction. (B) Promoter sequence and summary of the in vivo protein-DNA interactions on
the wild-type and endogenous DRA promoter. Long arrows, protections; short arrows, weaker protections; arrowheads, enhancements. The shaded
areas represent the functionally defined elements, except the octamer element which is not utilized in U373-MG cells (Wright and Ting, 1992). The
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Fig. 3. In vivo genomic footprints of stably maintained mutants of the HLA-DRA promoter reveal that CCAAT box binding is required for binding
of Xl/X2-specific proteins. (A) Upper strand in vivo footprints. The introduced promoter was revealed using a primer set specific for the vector
sequence of the original plasmid construct. (B) In vivo genomic footprints on the lower strand. The introduced promoter was revealed with a primer
set specific for the CAT coding sequence. The cell line class is indicated below each pair of lanes. Multiple footprint reactions of at least two
independent preparations of genomic DNA from three or more independent cell lines of each class were examined. The contacts indicated for each
cell line class were determined to be highly reproducible. The open diamonds represent partial protections present in the X2 region of the mutX2



















regulation of the introduced constructs, as previous studies
have shown maximal protein binding after y-IFN stimula-
tion (Wright and Ting, 1992). Gene-specific primer sets
were directed to either the genomic sequences flanking
the endogenous DRA promoter or to the CAT and vector
sequences flanking the stably integrated DRA promoter.
These primer sets enabled us to visualize the protein-DNA
interactions at both the endogenous and the introduced
DRA promoters in the same cell. In monoclonal stable
cell lines with one to six copies of exogenous DNA the
in vivo protection signal of the introduced DNA was
comparable to the endogenous DRA promoter (Figure 2).
Low copy number cell lines were specifically chosen to
alleviate potential titration of available factors. Guanine
residue contact points are spread throughout the XI and
X2 regions on both strands, while the Y/CCAAT element
displays contacts only on the upper strand. Although the
S element is functionally important, we and another group
have been unable to observe in vivo contacts directly
attributable to this site (Kara and Glimcher, 1991; Wright
and Ting, 1992). These results establish the validity of
studying stably transfected DRA promoter constructs in
terms of regulated promoter usage in vivo and provide a
system for pursuing the analysis of promoter assembly.
A hierarchy of protein- DNA interactions regulate
promoter assembly
In vivo footprint analysis of cell lines containing a mutation
of the DRA Y/CCAAT box (mutY) reveals a loss of
protein-DNA interaction within the Y/CCAAT box, as
would be expected (Figure 3A, lanes 3 and 4). More
importantly, interactions in the XI and X2 regions are
also significantly altered in vivo (Figure 3A and B, lanes
3 and 4). All seven of the X1I/X2 contact points on the
lower strand and four of the seven contacts on the upper
strand are lost. Only three enhancements (-117, -95 and
-83 bp) on the upper strand are consistently observed
when the Y/CCAAT box is mutated. The origin of these
enhancements is as yet unknown and could represent
residual binding in the absence of Y/CCAAT binding or
simply reflect the conformation of DNA in that area.
However, it is apparent that mutation of the Y/CCAAT
box dramatically altered binding over the X element/
CCAAT region. Identical results were obtained from
four independent monoclonal cell lines with varying low
numbers of integrated copies. Furthermore, this effect is
specific for the CCAAT box mutated promoter, as the
endogenous DRA promoter in the same cells is completely
loaded with protein at each of the sites (Figure 2A, lanes
3 and 4).
In stark contrast to the global effect of the Y/CCAAT
box mutation is the very localized effect of mutations in
the S element. The S element, although functionally
important in in vivo CAT assays (Figure IC), did not alter
any of the observable protein-DNA interactions when
mutated to a non-functional sequence (Figure 3A and B,
lanes 9 and 10). This result demonstrates distinct roles
for cis-acting elements in promoter complex formation
and emphasizes the central importance of Y/CCAAT
box binding.
X2 box mutations (mutX2) reduced interactions at the
X2 site, although this mutant does not completely abrogate
X2 binding in vivo (Figure 3B, lanes 5 and 6). The 3 bp
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Fig. 4. A polyclonal antiserum generated against a C-terminal peptide
of the NF-YA subunit specifically recognizes recombinant and native
NF-YA in Western blot, immunoprecipitation and shift-Western
analysis. (A) Western blot of nuclear extracts from the human B cell
lines Raji and Namalwa using anti-NF-YA antiserum. (B)
Immunoprecipitation analysis of recombinant radiolabeled NF-YA in
the presence and absence of crude nuclear extract. Lane 1, in vitro
translated NF-YA immunoprecipitated with anti-NF-YA without crude
nuclear extract; lane 2, in vitro translated NF-YA immunoprecipitated
with pre-immune serum; lane 3, in vitro translated NF-YA
immunoprecipitated with anti-NF-YA in the presence of crude nuclear
extract. (C) Shift-Western analysis reveals that NF-YA is contained
within the predominant gel-shift complex formed on a Y/CCAAT
element containing oligonucleotide. Lane 1, Western analysis of the
gel shift complex using pre-immune serum; lane 2, Western analysis
of the protein complexes using anti-NF-YA serum; lane 3,
autoradiography of the DNA migration pattern of the gel-shift. Arrows
depict alignment of the gel-shift complex with the NF-YA protein
identified in Western analysis.
mutation within X2 corresponds to the absence of three
bands on the upper strand in both the control and DMS
lanes due to this mutation (Figure 3A, lanes 5 and 6). The
3 bp mutation introduced in the X2 site is not sufficient
to completely eliminate protein binding at X2 in vivo, as
revealed by the weak protections still present on the lower
strand (Figure 3B, lanes 5 and 6). Thus the ability of the
X2 mutation to function upon y-IFN stimulation (Figure
IC, mutX2) may reflect stabilization of the X2 proteins
in the context of the integrated promoter. Interestingly,
binding at the XI site was slightly reduced compared with
the wild-type promoter (Figure 3A and B, lanes 5 and 6
versus lanes 1 and 2). The Y/CCAAT box interaction,
however, approaches the wild-type promoter footprint
(Figure 3A, lanes 5 and 6 versus lanes 1 and 2). Binding
at the Y/CCAAT box was verified by analysis of four
independent monoclonal cell lines in multiple footprint
reactions. The enhanced guanine residue on the lower
strand between the X2 and XI sites is derived from the
X2 mutation and therefore was not detectable in the wild-
type promoter (Figure 3B, lanes 5 and 6).
Mutation of the Xl sequence (mutXl ) resulted in a loss
of XI interactions as expected, but also a diminution of
interaction at the X2 box (Figure 3A and B, lanes 7
and 8). The X2 interactions are substantially abrogated,
however, binding is still detectable on both the upper and
lower strands at the same positions. The effect of Xl
mutations on the Y/CCAAT box are more difficult to
discern, because of the weak Y/CCAAT box protection
normally present in the wild-type and endogenous
promoters. Repeated in vivo footprint reactions of four
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Fig. 5. Immunoprecipitation of NF-Y co-precipitates two X box specific complexes. (A) Schematic of the method used to identify proteins
interacting with native and recombinant NF-YA. B cell nuclear extracts were combined with in vitro translated NF-YA and NF-YB and then
immunoprecipitated with antiserum generated against NF-YA or pre-immune serum. Proteins which interacted with NF-Y were analyzed for X box
DNA binding activity. (B) Gel-shift analysis of the eluate reveals that two X-specific protein-DNA complexes (large arrows) immunoprecipitate
with NF-Y. Non-specific interactions are indicated by small arrows. PI is pre-immune and I is immune precipitation. Lanes 1 and 2, 300 mM KCI
elution; lanes 3 and 4, 500 mM KCI elution; lanes 5 and 6, 700 mM KCl elution; lanes 7-12, direct binding of the 500 mM eluates to unrelated
oligonucleotide probes as indicated above each lane; lanes 13 and 14, as lanes 5 and 6; lane 15, immunoprecipitation of recombinant OTF-2 with
anti-OTF-2 antibodies reveals no X box binding factors. (C) Gel-shift competition of the NF-Y immunoprecipitated proteins identifies both Xl and
X2 proteins. The gel-shift probe was the wild-type X1I/X2 sequence and the extract was the 500 mM eluted fraction. Lanes 1-3, XI/X2 competitor;
lanes 4-6, mutated XI/wild-type X2 competitor (Xlmut); lanes 7-9, wild-type X1/mutated X2 competitor (X2mut); lanes 10-12, unrelated octamer-
containing competitor (Octa). Each competitor was used at 10-, 25- and 50-fold molar excess as indicated.
independent monoclonal cell lines have established con-
tinued protection at the Y/CCAAT box when the Xl site
is mutated. These findings suggest that while Xl binding
is not required for interactions at other sites in the
promoter, Xl binding does stabilize and enhance X2
binding and may have a minimal effect on Y/CCAAT
box binding. These results reveal a hierarchy of
protein-DNA interactions leading to the formation of
a stable promoter complex and indicate a primary impor-
tance for the Y/CCAAT element. Y/CCAAT binding
proteins could act to recruit additional factors or stabilize
protein complex formation via direct protein-protein
interactions. Significantly, a recent report by Reith et al.
(1994) has shown NF-Y stabilizes DNA binding of an Xl
factor in vitro. To address the potential for direct inter-
actions between X and Y factors, several in vitro bio-
chemical analyses were performed.
The CCAAT box binding protein NF-Y binds the
DRA Y element
Previous studies have shown that the transcription factor
NF-Y binds the CCAAT sequence of a number of
genes, including the MHC class II DRA (Dorn et al.,
1987; Oikarinen et al., 1987; Chodosh et al., 1988a;
Raymondjean et al., 1988). To directly examine whether
NF-Y interacts with X box binding proteins, we generated
a polyclonal antiserum against a C-terminal peptide of the
NF-YA subunit. The specificity of this antiserum was
identified as follows: (i) Western blot analysis of nuclear
extracts from two human B cell lines with this antibody
revealed a protein of identical molecular weight (40 kDa)
to that reported for the NF-YA subunit (Figure 4A; Hooft
van Huijsduijnen et al., 1990; Maity et al., 1990); (ii)
immunoprecipitation analysis with this antiserum shows










by the immune serum but not the pre-immune serum
(Figure 4B); (iii) shift-Western analysis revealed NF-Y
protein in the protein-DNA complex formed on the
Y/CCAAT element (Figure 4C). The position of NF-Y
located by Western analysis with the anti-NF-YA antibody
(lane 2) and the radiolabled gel-shifted complex (lane 3)
aligned completely, indicating that the NF-YA subunit
is present in the gel-shifted complex which binds the
CCAAT element.
Endogenous X box binding activity can be eluted
from immunoprecipitates of NF-Y
To assess directly the potential for interactions between
NF-Y and X element binding proteins, we used the
co-immunoprecipitation regime depicted in Figure 5A. In
this scheme in vitro translated NF-YA and NF-YB proteins
were combined with crude nuclear extract prior to immuno-
precipitation with anti-NF-Y antibodies. The association
ofX element binding proteins with NF-Y was subsequently
determined by elution of the immunoprecipitated complex
with a salt gradient, followed by gel-shift analysis of the
eluate for X element binding activity. We chose this
strategy to assess putative interactions in an effort to
maximize our recovery of NF-Y-associated proteins, as
previous attempts at direct immunoprecipitation were
unsuccessful.
The co-precipitation of X element binding activity with
NF-Y reflects interaction of at least two proteins. As
shown in Figure 5B, precipitation of two X element
binding proteins was significantly greater with anti-NF-Y
immune serum than with the control pre-immune serum.
Maximum differential elution typically peaked at -500
mM KCl. A slower migrating, non-specific band was
precipitated by both immune and pre-immune sera and
primarily eluted at the lower 300 mM salt concentration
(small arrow). To confirm the specificity of the co-
precipitation, two control experiments were performed.
First, we tested whether the precipitation of the in vitro
translated NF-Y resulted in a general isolation of DNA
binding proteins. DNA binding activity in the 500 mM
KCl eluate was tested on an octamer, MRRE, and E2F
binding site (Figure 5B, lanes 7-12). Only the same non-
specific band was detected in each case, confirming the
specificity of the NF-Y and X precipitation. The second
control was to test whether any combination of DNA
binding protein and its antibody would precipitate the X
box binding factors detected by NF-Y. We repeated the
co-immunoprecipitation scheme replacing the in vitro
translated NF-YA and B with in vitro translated OTF-2,
followed by precipitation with anti-OTF-2 antibodies. The
OTF-2 transcription factor is known to bind to the octamer
recognition sequence present within this same DRA
promoter. OTF-2 was unable to co-precipitate the X box
binding proteins (Figure SB, lanes 13-15).
The X element binding proteins specifically precipitated
with NF-Y were further characterized by gel-shift competi-
tion analysis using oligonucleotides containing mutations
within the XI or X2 elements (Figure SC). Both complexes
were efficiently competed by a 10-fold excess of homolog-
ous competitor (Figure SC, lane 1). Mutation of the XI
box produced a significantly less efficient com-
petitor, while mutation of the X2 element partially
weakened the competition. A competitor with a mutated
competitor, - fr.coo. Ab: - a
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Fig. 6. DNA affinity purification of X proteins retains NF-Y
Y/CCAAT box binding activity retained on an X1/X2 DNA affinity
column and eluted in fractions 58-62 was revealed by gel-shift
analysis (lanes land 5). The arrow marks the predominant band which
co-migrates with the NF-Y complex from crude extracts (data not
shown). Binding reactions for lanes 1-4 used only 25 ng poly(dI:dC)
non-specific competitor, while lanes 5-9 used 100 ng. Lanes 2-9 were
exposed five times longer than lane 1. Oligonucleotide competition:
lane 2, homologous competitor, Y/CCAAT (XY60mtX12); lane 3,
Xl/X2 competitor, (XY60mtY); lane 4, non-specific competitor, GC
box (antibodies specifically recognize NF-YA in the complex); lane 6,
pre-immune serum; lane 7, anti-NF-YA antibody; lane 8, anti-Spl
antibody; lane 9, anti-YB-lantibody. The anti-NF-YA antibody did not
interact with the DNA alone (data not shown).
Xl sequence (Xlmut, lanes 4-6) competed poorly at a
10-fold molar excess, yet abolished the signal at higher
concentrations. A competitor with a mutated X2 element
(X2mut, lanes 7-9) competed nearly as well as the wild-
type competitor at all concentrations. An unrelated octamer
competitor did not compete (lanes 10-12). The different
efficiencies of XI and X2 sequences to compete with
these bands are confirmed by direct binding to DNA
probes mutated in either site (data not shown). These
results show that proteins binding to the XI sequences
and potentially the X2 sequences are co-precipitated with
NF-Y molecules. One interpretation of this result is that
both Xl and X2 box binding proteins are involved in
the complex and that both are required for maximal
stabilization of the protein-DNA complex. This is in
agreement with the in vivo footprint analysis, which shows
XI and X2 binding are interdependent.
DNA affinity purification ofX box binding proteins
retains NF-Y
A classical method to isolate DNA binding proteins is to
exploit the high affinity protein-DNA interaction by
column chromatography on immobilized DNA binding
sites (Kadonaga and Tjian, 1986). Our laboratory and
others have used this procedure to isolate candidate X
box binding proteins (Y.Itoh-Lindstrom, in preparation).
We have now examined whether NF-Y could be specific-
ally retained during the purification of the X box binding
factors. A priori, NF-Y does not bind to the X box probe
directly because neither in vitro translated nor affinity
purified NF-Y bound this probe (data not shown; Zeleznik-
Le et al., 1991). Crude Namalwa B cell nuclear extract
was initially passed over a heparin-agarose column
followed by three successive purifications over an XI/
X2 DNA affinity column. X box binding activity was
monitored by gel-shift analysis on an X1/X2 DNA probe.
After the final purification, fractions containing distinct X
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box binding activities were pooled and assayed for
Y/CCAAT box binding. Fractions 58-62, eluting in a
linear gradient at -600 mM KCl, displayed Y/CCAAT
box binding activity (Figure 6, lane 1). No other DNA
binding activities could be detected in this fraction (data
not shown). The small amount of protein present in this
fraction made the Y/CCAAT box binding sensitive to
excess competition from the non-specific competitors
poly(dI:dC) and poly(dI):poly(dC). However, as shown in
Figure 6 (lanes 1 and 5), significant binding could be
detected at both 25 and 100 ng poly(dI):poly(dC). Lane
1 was exposed for a five times shorter period to produce
a comparable signal. Oligonucleotide competition with
several unrelated probes significantly reduced the band
intensity (lanes 2-4). However, only the Y/CCAAT ele-
ment completely removed the band. Direct evidence for
the presence of NF-Y was shown using the antibody to
the NF-YA subunit. The anti-NF-YA antibody recognized
and retarded the migration of the Y/CCAAT gel-shift
band (lane 7). Neither pre-immune serum nor anti-Spl
antibodies could recognize this band (lanes 6 and 8).
Antibodies directed against another Y box binding protein,
YB- 1, could not recognize this band (lane 9). Furthermore,
in the absence of protein the anti-NF-YA antibody did not
alter the mobility of the probe (data not shown). In
addition, as a direct control for the lack of NF-Y binding
directly to the X1/X2 DNA affinity matrix, recombinant
NF-Y or OTF-2 were passed over the X1/X2 DNA column.
Both proteins eluted primarily in the 100 and 200 mM
KCI loading buffer, while neither were present in the 600
mM KCI fraction (data not shown). This excludes the
possibility that NF-Y is directly and specifically binding
the X1/X2 affinity matrix. Thus we have been able to
isolate endogenous NF-Y proteins using DNA-bound
endogenous X box binding factors. In a reciprocal manner,
endogenous X box factors could be isolated by co-
precipitation with recombinant NF-Y protein (Figure 5).
These data together provide strong direct evidence for
interactions between endogenously produced NF-Y with
X box binding proteins. The exact identity of the X
element binding proteins is unclear. Although several Xl
and X2 box binding proteins have been reported, their
functional importance in DRA gene regulation is not
entirely clear and we have not been able to specifically
identify them in these experiments.
Discussion
Regulation of transcription requires many levels of
protein-DNA and protein-protein interactions at the
proximal promoter and at distally located promoter/
enhancer elements. Furthermore, the chromatin structure
surrounding a gene can greatly influence transcriptional
activity, most likely by altering accessibility of the tran-
scription factors to the DNA. This report focuses on the
CCAAT box binding factor NF-Y, which is required in
the regulation of a large number of genes, including
MHC class II DRA. Several lines of evidence have been
presented to demonstrate that NF-Y interacts with proteins
binding to the upstream elements (Xl and X2) in the
DRA promoter and that this interaction is crucial for gene
transcription: (i) a functional requirement for alignment
between the X and Y elements; (ii) in vivo X box binding
requires Y/CCAAT box occupancy; (iii) specific isolation
of NF-Y or X box binding proteins reciprocally isolates
the other protein from nuclear extracts.
Stereo-specific alignment of the X box and Y/CCAAT
element is required for optimal function (this report; Vilen
et al., 1990, 1992). In addition, the absolute distance
between the elements is of minor importance compared
with the alignment, since as many as eight helical tuns
can separate them before function is affected. This was
the first evidence to suggests that X box and Y/CCAAT
binding proteins either interact directly or are part of a
larger transcription complex which assembles on one
phase of the DNA helix. The significance of this alignment
is reiterated by the observed evolutionarily conserved
spacing in all MHC class II promoters. Stereo-specific
alignment has been reported for several other promoters
(Takahashi et al., 1986; Pape et al., 1990; Waibel and
Filipowicz, 1990; Harvey et al., 1991), as well as specific
distance requirements (Wu and Berk, 1988). Ivterestingly,
two examples involve the NF-Y protein. On the f-actin
promoter, the NF-Y site must also be stereo-specifically
aligned with a CCArGG box which binds p67s51
(Danilition et al., 1991). In addition, spatial constraints
are seen in the albumin promoter, where efficient activation
of transcription by NF-Y and C/EBP requires juxtaposi-
tioning of these two sites (Milos and Zaret, 1992). These
structural requirements are usually interpreted as involving
protein-protein interactions. The repeated occurrence of
this phenomenon also suggests that the DNA plays an
important role in defining which protein-protein inter-
actions will occur in vivo. A requirement for alignment
by DNA may be necessary to prevent inappropriate
interactions from taking place outside of a promoter region
and may compensate for weak affinities between distinct
transcription factors.
A second line of evidence indicating an X-Y interaction
came from the in vivo genomic footprint analysis, which
reveals a hierarchial loading of transcription factors onto
the DRA promoter. Occupancy at the Y/CCAAT element
served as a primary event that was required for occupancy
of the adjacent Xl and X2 sites. This is a particularly
important approach, because it defines the interdependence
of DNA binding in the context of the chromatin environ-
ment of the intact cell. This provides a certain level of
significance to pursue the in vitro interaction studies. A
few endogenous promoters have been examined for in vivo
DNA interactions. While most have involved constitutive
interactions and thus have not been able to address
interdependence, a few have examined inducible or
tissue-specific promoters. Induction of c-fos transcription
by epidermal growth factor revealed no changes in DNA
binding across the promoter (Herrera et al., 1989). How-
ever, a role for disruption of chromatin structure upon
binding of a specific factor has been described in several
other promoters. For example, glucocorticoid receptor
(GR) binding is required to permit NF-1 binding at an
adjacent site (Pina et al., 1990; Archer et al., 1991). The
role of GR binding appears to be in disrupting the
chromatin structure at the NF-1 site. GR binding seems
to play a similar role at the tyrosine aminotransferase
promoter (Becker et al., 1986; Carr and Richard-Foy,
1990; Rigaud et al., 1991). Tissue-specific expression of
the serum albumin gene involves chromatin disruption by
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HNF-3-like factors, presumably to promote the recruitment
of ubiquitous factors (McPherson et al., 1993). While
it is unclear if these factors also function by direct
protein-protein contact, a similar role for NF-Y could be
envisioned at the DRA promoter. Coordinate in vivo
binding of constitutive and regulated factors has been
demonstrated for the interleukin-2 (IL-2) promoter (Garrity
et al., 1994). Cells expressing IL-2 display factor binding
at many sites within the first 300 bp of the promoter,
while non-expressing cells have no in vivo binding. When
expressing cells are treated with cyclosporin-A to deplete
only a small subset of the factors, in vivo binding is lost
at all of the promoter sites. This suggests a hierarchy
of interactions dependent on a cyclosporin-A sensitive
component and is similar to the role we have proposed
for NF-Y on the DRA promoter.
While this manuscript was in preparation, Kara and
Glimcher reported a similar analysis of the DRA promoter
in B cell lines which constitutively express high levels of
DRA, as well as in mutant cell lines lacking DRA
expression (Kara and Glimcher, 1993). In DR-positive B
cell lines, the interdependency between X1, X2 and Y/
CCAAT was not revealed. The key difference between
these two studies is that they analyzed site interdependence
during constitutive expression in a B cell line. The
difference in the two analyses may be explained by
the in vivo footprint analysis showing that constitutive
expression exhibits maximal transcription factor binding,
whereas protein binding affinities in the y-IFN inducible
cells used in this study is suboptimal and modulated
upon y-IFN treatment (Wright and Ting, 1992). In the
y-IFN inducible system, interactions between DNA bind-
ing proteins may be required to stabilize this lower affinity
protein-DNA complex. Another possibility is that the
octamer site, which is unoccupied in the glioblastoma cell
line but occupied in the B cell lines (Wright and Ting,
1992), may alter the observable protein-protein inter-
actions at other sites. Thus, our ability to show inter-
dependency of DNA binding may be a direct reflection
of the cell system used.
Several lines of biochemical evidence suggest that
NF-Y may exert its function by direct protein-protein
interaction with X box binding factors. First, recombinant
NF-Y specifically co-precipitated X box binding factors,
while another recombinant transcription factor (OTF-2)
important for DRA could not. Secondly, endogenous NF-
Y was shown to be co-purified during the isolation of
endogenous X box binding proteins. Although, the identity
of the X box protein involved in this co-purification is as
yet unknown, this experiment is significant, due to the
use of only endogenous proteins. This alleviates concerns
that the use of excess recombinant proteins may promote
artificial interactions. Lastly, the in vitro binding stability
of at least one X box binding protein was increased when
NF-Y was bound to the adjacent CCAAT box (Reith et al.,
1994; K.L.Wright, unpublished observation). Reith et al.
have recently reported a large stabilization ofRFX binding
and a small stabilization of NF-Y when the other protein
was present on the DNA. Combined, the stabilization
studies and the reciprocal isolation ofX and NF-Y proteins
provide strong evidence that these protein can directly
interact in vitro and suggests a mechanism for the











Fig. 7. NF-Y acts as a central nucleating factor in recruiting or
stabilizing upstream protein binding through direct interaction with X
element-specific proteins. In model 1 mutations within the Y/CCAAT
sequence prevent NF-Y binding and subsequent binding at the X1/X2
sites. In model 2 an intact Y/CCAAT site allows NF-Y binding at the
Y/CCAAT site and either recruits proteins or stabilizes protein binding
at the XI/X2 sites. The helical orientation of the X1/X2 and Y/
CCAAT sites is critical for alignment of the proteins for interactions
and mis-alignment may lead to weakened X box binding. The bending
of the DNA is for simplicity of viewing and has not been
demonstrated. Star indicates XI/X2 interdependence.
intermediary factor cannot be excluded at this point.
This report provides a basis for a working model where
binding of NF-Y to the Y/CCAAT element is an early
and requisite event in the assembly of the DRA proximal
promoter (Figure 7). This binding is essential for
subsequent occupation of the XI and X2 elements by
transcription factors. The biochemical evidence suggests
that NF-Y recruits XI and X2 proteins to the promoter
by direct protein-protein interactions. The requirement
for helical alignment indicates that such protein-protein
interactions are disrupted if the bound proteins do not
align on the same phase of theDNA helix. When occupying
the same phase of the DNA, NF-Y may stabilize the
binding of X box proteins to their respective target sites
by serving as an anchoring molecule and/or by inducing
conformational alterations in these proteins resulting in
enhanced affinity for their DNA target sites. Additional
interactions between the XI and X2 binding proteins also
seem to occur, as suggested by the in vivo footprint
and the co-precipitation analyses. The co-dependency of
proteins binding to the XI and X2 elements may also
reflect stabilization via protein-protein interactions,
although direct evidence is required to prove this
possibility.
The abundance of genes containing a CCAAT element
within the proximal promoter makes the CCAAT box
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binding factors potential candidates to serve a more general
role in transcriptional regulation (McKnight and Tjian,
1986; Mitchell and Tjian, 1989). In many promoters, the
CCAAT element is located -60-80 bp upstream of the
start site of transcription. Although CCAAT elements can
be found elsewhere in the regulatory regions of other
genes, a survey of known NF-Y target sites show that its
location is typically confined to the -60 to -130 region
and most proximally located CCAAT elements precisely
reflect the NF-Y target sequence, not those for C/EBP or
NF-l (Bucher, 1990). Further evidence for a general role
for NF-Y in the formation of a proximal promoter complex
is provided by recent studies of the MHC class II Ea
gene and the albumin gene, demonstrating that NF-Y
functions early in pre-initiation complex formation
(Mantovani et al., 1992; Milos and Zaret, 1992).
These studies show that antibodies to NF-Y can block
re-initiation of transcription in both genes (Mantovani
et al., 1992). The in vivo findings presented here show that
proteins binding to the upstream elements are dependent on
loading at the CCAAT site and that binding of the
Y/CCAAT element by NF-Y provides a central nucleating
point in recruiting additional proteins to the proximal
promoter by protein-protein interaction. This is reminis-
cent of protein complex formation on the basal promoter
when TFIID binding to the TATA element initiates protein
complex formation involving direct interactions with
several components of the basal machinery, including
TFIIA and TFIIB (reviewed in Roeder, 1991). Our results
would suggest that NF-Y plays a similar role in initiating
protein complex formation among upstream activating
elements. Considering the prevalence of Y/CCAAT sites
in multiple eukaryotic promoters, interactions between
NF-Y and other transcription factors are likely pivotal
steps in transcriptional regulation and are deserving of
intense investigation.
Materials and methods
Cell culture and transient transfection
Raji is a human Epstein-Barr virus-positive Burkitt's lymphoma cell
line that expresses high levels of MHC class II antigens. These cells
were grown in RPMI 1640 supplemented with 8% fetal calf serum and
2 mM glutamine. The U373-MG cell line is a glioblastoma multiform
cell line which expresses low basal levels and high y-IFN-induced levels
of MHC class II antigens (Basta et al., 1987). These cells were maintained
in McCoy's 5A with 10% fetal calf serum, 2 mM glutamine, 100 U
penicillin and 100 gg/mI streptomycin. Transient transfections were
performed by electroporation as previously described (Sherman et al.,
1987).
Constructs
The wild-type DRA promoter construct, 5'A-56SXY, which contains the
first 141 bp of the DRA promoter fused to the chloramphenicol
acetyltransferase (CAT) reporter gene, and the mutants SX+5Y,
SX+ lOY, S+5XY and S+ lOXY derived from this construct have
been previously described (Vilen et al., 1992). Briefly, overlapping
oligonucleotides corresponding to the -141 to -98 bp region of DRA
(including S and X) and the region from -109 to -61 bp (including X
and Y) were made double-stranded using reverse transcriptase (Life
Sciences) and then cloned into the XbaI site of 5'A-56 to create the
wild-type construct. The mutant constructs contained either the 5 bp
insert sequence TGCAG or the 10 bp insert sequence TGCAGGTCGC.
Dideoxynucleotide sequencing was performed directly from the double-
stranded plasmid to confirm the sequences of all constructs. The parent
plasmids used to generate the giant spacer constructs X+ 1.5Y and
X+2.OY, containing one and a half or two additional turns of the DNA
helix between the X and Y motifs, have been previously described
(Vilen et al., 1990) (therein referred to as pSpacer+ 15 and pSpacer+20).
Additional constructs with increasing numbers of half integral and
integral helical turns were made by inserting multiple copies of the
sequence GTCGCTGATCATGTGTCTGCA, representing two helical
turns, into the unique PstI site created in X+1.5Y and X+2.OY. One
and two copies of this sequence inserted into X+ l.5Y generated X+3.5Y
and X+5.5Y respectively, while one and two copies inserted into
X+2.OY generated X+4.OY and X+6.OY respectively.
The constructs used to generate the stable cell lines have been
described previously (Moses et aL, 1992). Briefly, the wild-type DRA
construct (5'A-152DRA-CAT) contains the first 152 bp of the DRA
promoter fused to the CAT reporter gene and subcloned in the pBluescript
SK+ vector (Stratagene). Each of the mutant DRA constructs contain
selected point mutations as described previously (Moses et al., 1992)
(therein mutY, mutX2, mutXl and mutS are referred to as Y-M 1,
X-M2, X-M3 and S-M2 respectively). The neomycin selection marker
was carried on a separate plasmid, pSV2neo (Southern and Berg, 1982).
Stable cell line transfection and selection
Each circular construct (20 ig) was introduced independently into 4X 106
U373-MG cells by electroporation (200 mV, 960 jiF, 300 jl volume;
Bio-Rad Gene Pulser), together with a 1/20 molar amount of the
neomycin resistance gene pSV2neo. Selection with 300 U/ml G418
(Geneticin; Gibco) was begun 24-36 h after transfection. The amount
of G418 was determined empirically to completely kill mock-transfected
cells within 8-12 days. Individual resistant colonies were visible in
2-3 weeks, at which time the cells were cloned by limiting dilution and
expanded. Cell lines were always maintained in 300 U/ml G418, except
when harvesting cells for CAT activity determination (see below). The
conditions used to generate the stable lines were intended to decrease
the frequency of integration and thereby enhance the percentage of low
copy number transfectants in the surviving population. More than 80%
of the examined monoclonal cell lines contained 10 or less copies
of the test plasmid, as determined by quantitative Southern blot analysis
(Southern, 1975). DNA copy number was also shown to be directly
proportional to the signal intensity of the ligation-mediated PCR
sequencing ladder and was used as an additional confirmation of relative
DNA copy number.
CAT reporter gene analysis
Following transfection, the U373-MG cells were treated with recombinant
y-IFN at 500 U/ml for 24-48 h prior to harvest. The human recombinant
y-IFN was a generous gift from Biogen (Cambridge, MA). The Raji cell
transfections were harvested 24 h following electroporation. The stable
cell lines were removed from G418 antibiotic selection two passages
before harvest and CAT quantitation. Expression of both the transiently
transfected and the stably transfected reporter genes was assayed by
quantitating CAT activity in cell extracts as previously described
(Sherman et al., 1989). CAT activity was resolved on thin-layer chromato-
graphy plates and quantitated with a Molecular Dynamics Phosphor-
Imager. Fold induction was calculated by dividing the percent acetylation
in y-IFN-treated cultures by the analogous untreated controls.
In vivo footprinting
In vivo methylation of cells and DNA preparation were as described
(Pfeifer et al., 1990). The ligation-mediated PCR-amplified in vivo
genomic footprinting was as originally described by Mueller and Wold
(1989) and modified by Wright and Ting (1992). The primers used to
reveal the endogenous DRA promoter were as described previously. The
primers to reveal the stably introduced DRA constructs were targeted to
the vector and CAT coding sequences. Primer sets used to reveal the
lower strand correspond to vector sequences of the BlueScript plasmid
(Stratagene) and are: SKVEC primer 1, 5'-CACACAGGAAACAGC-
TATG-3' (Tm = 56°C); SKVEC primer 2, 5'-GCTCGGAATITAACCC-
TACCTAAAGGGAAC-3' (Tm = 62°C); SKVEC primer 3, 5'-
AACCCTCACTAAAGGGAACAAAAGCTGGAGC-3' (Tm = 63°C).
Primer sets to display the upper strand correspond to the CAT coding
sequence and are: PCAT primer 1, 5'-CAACGGTGGTATATCCAGTG-
3' (Tm = 58°C); PCAT primer 2, 5'-CTTCCTITAGCTCCTGAAAATCT-
CGCCAAGC-3' (Tm = 63°C); PCAT primer 3, 5'-GCTCCTGAAAAT-
CTCGCCAAGCTCAGATCCTC-3' (Tm = 65°C).
Immunoprecipitation and Western blots
Polyclonal rabbit antisera were generated against synthetic peptides of
NF-YA or NF-YB by Animal Pharm Services, Inc. (San Francisco, CA).
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The peptide used as the immunogen for anti-NF-YA was NH2-C-
DEEAMTQIIRVS-COOH conjugated to KLH. The peptide for the
production of anti-NF-YB has been reported previously (Mantovani
et al., 1992). High titer antisera was subsequently purified by passage
over protein A/protein G-Sepharose columns as described by the
supplier (Pierce, Rockford, IL). Antibody specificity was confirmed as
described in the text (see Figure 4). Immunoprecipitation and Western
blot analysis were performed using standard protocols (Gallagher et al.,
1989; Springer, 1992). Western blots were blocked with 1% gelatin 1 h
prior to incubation with primary antibody. Blots were developed using
the ECL detection system (Amersham).
Gel-shift analysis and shift-Western analysis
Gel-shift reactions were performed as previously described (Vilen et al.,
1990). Binding reactions were carried out in 10% glycerol, 50 mM
NaCl, 10 mM Tris-HCI, pH 7.9, 2.5 mM MgCl2, 0.5 mM EDTA,
1 mM DTT with 50 ng-2 jg poly(dI:dC) (Pharmacia) in a 20 p1 volume
at room temperature for 15 min. The samples were resolved by
electrophoresis through 5% or 6% native polyacrylamide gels with a
TGE running buffer (25 mM Tris-HCl, pH 7.9, 190 mM glycine,
1 mM EDTA). The sequence of the oligonucleotide probes used for






AATATTT TFTCGGAGGTTCCAAAGAG; GC element, GCCTGTTCC
TCGTACTAGCCGAGAGCCCCGCCCTCGTTCCCTCC. Antibody
supershift of NF-Y complexes was performed by including 1 jg anti-
NF-YA antibody in the gel-shift reaction mix for 2 h on ice without the
DNA probe. The probe was then added and the reaction continued for
20 min prior to loading onto the gel. Shift-Western analysis was
performed essentially as previously described (Demczuk et al., 1993).
In vitro transcription and translatioq reactions
Human NF-YA, NF-YB and OTF-2 cDNA clones for in vitro transcription
were generated by PCR amplification of reverse-transcribed Namalwa
B cell mRNA and subsequent ligation into pGEM 3Zf+ (Promega).
Primers, amplification and other cloning details are described elsewhere
(J.B.Clarke, in preparation). In vitro transcription reactions were per-
formed as described by the manufacturer (Promega, Madison, WI). The
DNA template was removed following transcription by adding RQl
RNase-free DNase (Promega) to a concentration of 1 U/mg DNA
followed by incubation for 30 min at 37°C. The RNA products were
purified by passage over pre-packed Sephadex G50 spin columns as
described by the manufacturer (Boehringer-Mannheim, Indianapolis, IN).
In vitro translation reactions were performed using wheatgerm or rabbit
reticulocyte lysates as per the manufacturer's instructions (Promega).
Each reaction contained -500 ng RNA, which was heated at 67°C for
10 min and then immediately cooled on ice. Reactions containing
radiolabeled proteins used 4 ,ul [35S]methionine (1200 Ci/mmol at
10 mCi/ml; DuPont-New England Nuclear). Unlabeled reactions used
1 ,ul 10 mM methionine. Labeled reaction products were analyzed on
SDS-PAGE gels and translation products were stored at -70°C.
Immunoprecipitation/protein elution
Approximately 400 jig Namalwa B nuclear extract was mixed with
30 jl each recombinant in vitro translated NF-YA and NF-YB and
incubated at 4°C for 1 h in a buffer of 17% glycerol, 20 mM HEPES,
pH 7.9, 100 mM KCl, 0.2 mM EDTA, 0.2 mM EGTA, 12.5 mM MgCl2,
2 mM DTT, 1 mM PMSF. Antibodies to NF-YA and NF-YB (-50 jig
each) were subsequently added and the reaction was further incubated
for 4 h at 4°C. Protein A-agarose (100 g1) was then incubated with the
mixture overnight at 4°C, centrifuged to pellet the agarose beads and
then washed four times with phosphate-buffered saline/0.05% NP-40.
Step elution of the interacting proteins was done with 150 pl buffer
containing 300, 500 or 700 mM KCI in 250 mM Tris, pH 8.0, 2 mM
EDTA, 1% NP-40, 0.5 mM DTT, 0.5 mM PMSF, 20% glycerol. Collected
fractions were dialyzed overnight against elution buffer containing
100 mM KCI. Samples were immediately assayed for DNA binding
activity. Control precipitations of OTF-2 were performed with a pepetide-
derived antibody from Santa Cruz Biotechnology, Inc.
DNA affinity protein purification
The purification is described in detail elsewhere (Y.Itoh-Lindstrom, in
preparation). Briefly, Namalwa B cell nuclear extracts were initially
chromatographed on a heparin-agarose (Sigma) column and eluted with
a linear gradient of 100-1000 mM KCl. X box binding activity was
monitored by gel-shift analysis. Fractions containing X box binding
factors were pooled and chromatograhed three times on an X box DNA
affinity column by the method described by Kadonaga and Tjian (1986).
After the final purification, fractions containing distinct X box binding
complexes were pooled and assayed for Y/CCAAT box binding activity.
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